文献速递认知障碍与痴呆神经免疫

原发性中枢神经系统淋巴瘤的视神经浸润

Optic Nerve Infiltration in Primary Central Nervous System Lymphoma.
PubMed 文献 · JAMA Neurol · 2017-01-01

该回顾性研究从法国3家医院1998至2014年数据库中识别752例原发性中枢神经系统淋巴瘤(PCNSL)患者,其中7例存在视神经浸润(ONI)。ONI表现为快速进展的严重视力损害,MRI显示视神经强化,临床结局差,中位无进展生存期11个月,中位总生存期18个月。

要点

  • PCNSL患者出现快速进展的严重视力损害需警惕视神经浸润。
  • MRI显示视神经强化是ONI的关键影像学特征。
  • ONI患者视觉和全身预后差,中位总生存期仅18个月。

核心结论

  • 视神经浸润是PCNSL罕见且非典型的表现,视觉和全身预后极差。

主要发现

  • 7例患者中5例女性、2例男性,诊断时中位年龄65岁(范围49-78岁)。
  • 2例在初诊时存在ONI,5例在复发时出现ONI。
  • 所有患者均表现为快速进展的严重视力损害。
  • MRI显示3例视神经增粗,所有患者视神经均有对比强化;4例存在其他中枢神经系统病灶。
  • 脑脊液检查发现2例淋巴瘤性脑膜炎。

关键数值与推荐

  • 视神经浸润后中位无进展生存期为11个月(95%CI,9-13个月)。
  • 中位总生存期为18个月(95%CI,9-27个月)。
  • 临床结局:2例部分恢复,5例持续严重低视力或失明。

临床怎么用

  • PCNSL患者出现快速进展的严重视力损害时应考虑视神经浸润,并完善MRI检查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Visual impairment in primary central nervous system lymphoma (PCNSL) is caused mostly by intraocular lymphomatous involvement (vitritis and retinal infiltration), whereas optic nerve infiltration (ONI) is a rare condition. OBJECTIVE: To describe the clinical presentation of ONI, its imaging characteristics, and outcome. DESIGN, SETTING AND PARTICIPANTS: A total of 752 patients diagnosed with PCNSL were retrospectively identified from the databases of 3 French hospitals from January 1, 1998, through December 31, 2014. Of these, 7 patients had documented ONI. Exclusion criteria were intraocular involvement, orbital lymphoma, or other systemic lymphoma. Clinical presentation, neuroimaging, biological features, treatment, and outcomes were assessed. MAIN OUTCOMES AND MEASURES: Treatment response was evaluated clinically and radiologically on follow-up magnetic resonance imaging (MRI) according to the International PCNSL Collaborative Group response criteria. RESULTS: The 7 patients included 5 women and 2 men. Median age at diagnosis was 65 years (range, 49-78 years). Two patients had initial ONI at diagnosis, and 5 had ONI at relapse. Clinical presentation was marked by rapidly progressive and severe visual impairment for all patients. The MRI findings showed optic nerve enlargement in 3 patients and contrast enhancement of the optic nerve in all patients. Additional CNS lesions were seen in 4 patients. Examination of cerebrospinal fluid samples detected lymphomatous meningitis in 2 patients. Clinical outcome was poor and marked by partial recovery for 2 patients and persistent severe low visual acuity or blindness for 5 patients. Median progression-free survival after optic nerve infiltration was 11 months (95% CI, 9-13 months), and median overall survival was 18 months (95% CI, 9-27 months). CONCLUSIONS AND RELEVANCE: Optic nerve infiltration is an atypical and challenging presentation of PCNSL. Its visual and systemic prognosis is particularly poor compared with vitreoretinal lymphomas even in response to chemotherapy. Although intraocular involvement is frequent in PCNSL and clinically marked by slowly progressive visual deterioration, lymphomatous ONI is rare and characterized by rapidly progressive severe visual impairment.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Ahle G, Touitou V, Cassoux N, et al. Optic Nerve Infiltration in Primary Central Nervous System Lymphoma. JAMA Neurol. 2017. PMID: 28973119. doi:10.1001/jamaneurol.2017.2545

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。